Nutrition recommendations for the treatment and prevention of type 2 diabetes and the metabolic syndrome: An evidenced-based review

Nutrition Reviews

Volumn 64, Issue 9, 2006, Pages 422-427

  Mann, Jim I ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BODY WEIGHT; CARBOHYDRATE DIET; DIETARY FIBER; DIETARY REFERENCE INTAKE; ENERGY BALANCE; FAT INTAKE; GLYCEMIC INDEX; HUMAN; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN INTAKE; REVIEW; VITAMIN SUPPLEMENTATION;

DIABETES MELLITUS, TYPE 2; DIET; ENERGY INTAKE; EVIDENCE-BASED MEDICINE; HUMANS; METABOLIC SYNDROME X; NUTRITION POLICY; OBESITY; UNITED STATES;

EID: 33749524083     PISSN: 00296643     EISSN: 00296643     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2006.tb00227.x     Document Type: Review

References (45)

1. Scottish Intercollegiate Guidelines Network. SIGN 50: A Guideline Developer's Handbook. Available at: http://www.sign.ac.uk/guidelines/fulltext/ 50/index.html. Accessed August 8, 2006.
2. Mann JT, De Leeuw I, Hermansen K, et al., on behalf of the Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD). Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis. 2004;14:373-394.
3. Astrup A, Grunwald GK, Melanson EL, Saris WH, Hill JO. The role of low-fat diets in body weight control; a meta-analysis of ad libitum dietary intervention studies. Int J Obes Relat Metab Disord. 2000;24:1545-1552.
4. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord. 1992;16:397-415.
5. European Association for the Study of Obesity. Management of obesity in adults: project for European primary care. Int J Obes Relat Metab Disord. 2004;28(suppl 1):S226-S231.
6. Hauner H, Hamann A, Husemann B, et al. Prävention und Therapie der Adipositas. Evidenzbasierte Diabetes-Leitlinie DDG. Hrsg. Deutsche Adipositas-Gesellschaft, Deutsche Diabetes-Gesellschaft, Deutsche Gesellschaft für Ernährung. Diabetes und Stoffwechsel. 2003;12(suppl 2):35-46.
7. Nishida C, Uauy R, Kumanyika S, Shetty P. The Joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutr. 2004;7:245-250.
8. Lean ME, Powrie JK, Anderson AS, Garthwaite PH. Obesity, weight loss and prognosis in type 2 diabetes. Diabet Med. 1990;7:228-233.
9. Brage S, Wedderkopp N, Ekelund U, et al.; European Youth Heart Study (EYHS). Features of the metabolic syndrome are associated with objectively measured physical activity and fitness in Danish children: the European Youth Heart Study (EYHS). Diabetes Care. 2004;27:2141-2148.
10. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a metaanalysis. Ann Intern Med. 1996;124:627-632.
11. Ciavarella A, Di Mizio G, Stefoni S, Borgnino LC, Vannini P. Reduced albuminuria after dietary protein restriction in insulin-dependent diabetic patients with clinical nephropathy. Diabetes Care. 1987;10:407-413.
12. Bending JJ, Dodds RA, Keen H, Viberti GC. Renal response to restricted protein intake in diabetic nephropathy. Diabetes. 1988;37:1641-1646.
13. Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1991;324:78-84.
14. Raal FJ, Kalk WJ, Lawson M, et al. Effect of moderate dietary protein restriction on the progression of overt diabetic nephropathy: a 6mo prospective study. Am J Clin Nutr. 1994;60:579-585.
15. Hansen HP, Tauber-Lassen E, Jensen BR, Parving HH. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int. 2002;62:220-228.
16. Nair KS, Garrow JS, Ford C, Mahler RF, Halliday D. Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia. 1983;25:400-403.
17. Heine RJ, Mulder C, Popp-Snijders C, van der Meer J, van der Veen EA. Linoleic-acid-enriched diet: long-term effects on serum lipoprotein and apolipoprotein concentrations and insulin sensitivity in non-insulin-dependent diabetic patients. Am J Clin Nutr. 1989;49:448-456.
18. Vessby B, Unsitupa M, Hermansen K, et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia. 2001;44:312-319.
19. Perez-Jimenez F, Lopez-Miranda J, Pinillos MD, et al. A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons. Diabetologia. 2001;44:2038-2043.
20. Summers LK, Fielding BA, Bradshaw HA, et al. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia. 2002;45:369-377.
21. Romano G, Tilly-Kiesi MK, Patti L, et al. Effects of dietary cholesterol on plasma lipoproteins and their subclasses in IDDM patients. Diabetologia. 1998;41:193-200.
22. Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr. 1998;67(3 suppl):577S-582S.
23. Giacco R, Parillo M, Rivellese AA, et al. Long-term dietary treatment with increased amounts of fiberrich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care. 2000;23:1461-1466.
24. Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med. 2000;342:1392-1398.
25. Mann J. Dietary fibre and diabetes revisited. Eur J Clin Nutr. 2001;55:919-921.
26. Toeller M, Buyken AE, Heitkamp G, de Pergola G, Giorgino F, Fuller JH. Fiber intake, serum cholesterol levels, and cardiovascular disease in European individuals with type 1 diabetes. EURODIAB IDDM Complications Study Group. Diabetes Care. 1999;22(suppl 2):B21-B28.
27. Brand-Miller J, Hayne S, Petocz P, Colagiuri S. Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care. 2003;26:2261-2267.
28. Peterson DB, Lambert J, Gerring S, et al. Sucrose in the diet of diabetic patients - just another carbohydrate? Diabetologia. 1986;29:216-220.
29. Mann JI. Simple sugars and diabetes. Diabet Med. 1987;4:135-139.
30. Mann JI. Free sugars and human health: sufficient evidence for action? Lancet. 2004;363:1068-1070.
31. Poppitt SD, Keogh GF, Prentice AM, et al. Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome. Am J Clin Nutr. 2002;75:11-20.
32. Parillo M, Giacco R, Ciardullo AV, Rivellese AA, Riccardi G. Does a high-carbohydrate diet have different effects in NIDDM patients treated with diet alone or hypoglycaemic drugs? Diabetes Care. 1996;19:498-500.
33. Garg A, Bantle JP, Henry RR, et al. Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. JAMA. 1994;271:1421-1428.
34. Gerhard GT, Ahmann A, Meeuws K, et al. Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycaemic control in type 2 diabetes. Am J Clin Nutr. 2004;80:668-673.
35. Dodson PM, Beevers M, Hallworth R, Webberley MJ. Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. N Engl J Med. 2002;346:393-403.
36. Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Lithell H. The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes. 1994;43:1353-1357.
37. Manson JE, Rimm EB, Stampfer MJ, et al. Physical activity and incidence of non-insulin-cancers, type 1 diabetes, heart disease and osteoporosis. Lancet. 1991;338:774-778.
38. Laaksonen DE, Lakka TA, Lakka HM, et al. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med. 2002;19:456-464.
39. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537-544.
40. Tuomilhto J, Lindstrom J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344-1343-1350.
41. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
42. McAuley KA, Williams SA, Mann JI, et al. Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial. Diabetes Care. 2002;25:445-452.
43. Holick MF. Vitamin D: importance in the prevention of cancers, type I diabetes, heart disease and osteoporosis. Am J Clin Nutr. 2004;79:362-371.
44. Zhao HX, Mold MD, Stenhouse EA, et al. Drinking water composition and childhood-onset Type 1 diabetes mellitus in Devon and Cornwall, England. Diabetes Med. 2002;18:709-717.
45. Gale EA, Bingley PJ, Emmett CL, Collier T; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. European Nicotinamide Diabetes Intervention Trial (ENDIT): A randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet. 2004;363:925-931.